Kir6.1 knockdown aggravates cerebral ischemia/reperfusion-induced neural injury in mice.

Abstract:

BACKGROUND AND PURPOSE:ATP-sensitive potassium (K-ATP) channels couple energy metabolism with electric activity, which play important roles in brain diseases including stroke. However, the impacts of Kir6.1-containing K-ATP channels that mainly expressed on glia in stroke remain unclear. METHODS AND RESULTS:In this study, we found that expression of Kir6.1 was significantly decreased in the ischemic brain area of C57BL/6J mice after 1-h middle cerebral artery occlusion (MCAO) and 24-h reperfusion. Then, we subjected Kir6.1 heterozygote knockout (Kir6.1(+/-) ) mice to cerebral ischemia/reperfusion (I/R) injury and found that Kir6.1(+/-) mice exhibited exacerbated neurological disorder and enlarged infarct size, companied by glial over-activation and blood-brain barrier (BBB) damages. Furthermore, we showed that Kir6.1 knockdown aggravated endoplasmic reticulum (ER) stress and thereby increased the levels of proinflammatory factors tumor necrosis factor-α and interleukin-1β (TNF-α and IL-1β) in mouse brain. CONCLUSIONS:Our findings reveal that Kir6.1 knockdown exacerbates cerebral I/R-induced brain damages via increasing ER stress and inflammatory response, indicating that Kir6.1-containing K-ATP channels may be a potential therapeutic target for stroke.

journal_name

CNS Neurosci Ther

authors

Dong YF,Wang LX,Huang X,Cao WJ,Lu M,Ding JH,Sun XL,Hu G

doi

10.1111/cns.12117

subject

Has Abstract

pub_date

2013-08-01 00:00:00

pages

617-24

issue

8

eissn

1755-5930

issn

1755-5949

journal_volume

19

pub_type

杂志文章
  • Vagomimetic effects of fingolimod: physiology and clinical implications.

    abstract::Fingolimod is a sphingosine 1-phosphate (S1P) receptor modulator approved to treat relapsing-remitting multiple sclerosis (MS). Initiation of treatment with fingolimod has been found to produce transient bradycardia and/or slowing of atrioventricular impulse conduction in a small proportion of patients. This effect is...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12283

    authors: Vanoli E,Pentimalli F,Botto G

    更新日期:2014-06-01 00:00:00

  • Epidemiology of subarachnoid hemorrhage, patterns of management, and outcomes in China: a hospital-based multicenter prospective study.

    abstract:AIMS:To conduct a large-scale analysis on epidemiology, management, and outcomes of spontaneous subarachnoid hemorrhage (SAH), and to investigate the current situation of aneurysm obliteration in China. METHODS:A multicenter prospective cohort study involving 132 hospitals throughout China from September 2007 to Augus...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,多中心研究

    doi:10.1111/cns.12001

    authors: Bian LH,Liu YF,Nichols LT,Wang CX,Wang YL,Liu GF,Wang WJ,Zhao XQ

    更新日期:2012-11-01 00:00:00

  • β-phenethylamine--a phenylalanine derivative in brain--contributes to oxidative stress by inhibiting mitochondrial complexes and DT-diaphorase: an in silico study.

    abstract:AIM:Till date, the mode of action of β-PEA on neurons is not well illustrated. We tested the hypothesis that β-PEA has the ability to cause oxidative stress by inhibiting the antioxidant enzyme DT-diaphorase and mitochondrial complexes (Complex-I and complex-III). METHODS:Using molecular docking as a tool, we here stu...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12113

    authors: Mazumder MK,Paul R,Borah A

    更新日期:2013-08-01 00:00:00

  • Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.

    abstract:AIMS:In this study, we examined the expression of GINS2 in glioma and determined its role in glioma development. METHODS:The protein expression of GINS2 was assessed in 120 human glioma samples via immunohistochemistry. Then, we suppressed the expression of GINS2 in glioma cell strains U87 and U251 using a short hairp...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13064

    authors: Shen YL,Li HZ,Hu YW,Zheng L,Wang Q

    更新日期:2019-02-01 00:00:00

  • Use of statin during hospitalization improves the outcome after intracerebral hemorrhage.

    abstract:AIMS:To examine the relationship between statin use in Chinese patients with intracerebral hemorrhage (ICH) during their hospitalization and the outcomes. METHODS:Data were collected from the China National Stroke Registry. Good functional outcome was defined by a modified Rankin Scale score between 0-2. Functional ou...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12274

    authors: Pan YS,Jing J,Wang YL,Zhao XQ,Song B,Wang WJ,Wang D,Liu GF,Liu LP,Wang CX,Wang YJ,CNSR investigators.

    更新日期:2014-06-01 00:00:00

  • Pathological changes in neurovascular units: Lessons from cases of vascular dementia.

    abstract::Vascular dementia (VD) is the second leading cause of dementia after Alzheimer's disease (AD). The decrease of cerebral blood flow (CBF) to different degrees is one of the main causes of VD. Neurovascular unit (NVU) is a vessel-centered concept, emphasizing all the cellular components play an integrated role in mainta...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13572

    authors: Li C,Wang Y,Yan XL,Guo ZN,Yang Y

    更新日期:2021-01-10 00:00:00

  • Global White Matter Hypoperfusion on CT Predicts Larger Infarcts and Hemorrhagic Transformation after Acute Ischemia.

    abstract:INTRODUCTION:Presence of white matter hyperintensity (WMH) on MRI is a marker of cerebral small vessel disease and is associated with increased small vessel stroke and increased risk of hemorrhagic transformation (HT) after thrombolysis. AIM:We sought to determine whether white matter hypoperfusion (WMHP) on perfusion...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,多中心研究

    doi:10.1111/cns.12491

    authors: Bivard A,Cheng X,Lin LT,Levi C,Spratt N,Kleinig T,O'Brien B,Butcher K,Lou M,Zhang JF,Sylaja PN,Cao WJ,Jannes J,Dong Q,Parsons M

    更新日期:2016-03-01 00:00:00

  • Mutation Analysis of COQ2 in Chinese Patients with Cerebellar Subtype of Multiple System Atrophy.

    abstract:AIMS:Recently, mutations in COQ2 encoding para-hydroxybenzoate-polyprenyl transferase have been identified to increase the risk of multiple system atrophy (MSA) in multiplex families and sporadic cases. The prevalence of COQ2 mutations was showed to be higher in cerebellar subtype (MSA-C) than parkinsonism subtype (MSA...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12412

    authors: Wen XD,Li HF,Wang HX,Ni W,Dong Y,Wu ZY

    更新日期:2015-08-01 00:00:00

  • DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

    abstract::Alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) type glutamate receptors are critical for synaptic plasticity and induction of long-term potentiation (LTP), considered as one of the synaptic mechanisms underlying learning and memory. Positive allosteric modulators of AMPA receptors could provide a the...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1755-5949.2009.00088.x

    authors: Bernard K,Danober L,Thomas JY,Lebrun C,Muñoz C,Cordi A,Desos P,Lestage P,Morain P

    更新日期:2010-10-01 00:00:00

  • Brain structure alterations in depression: Psychoradiological evidence.

    abstract::Depression is the leading cause of disability around the world, but little is known about its pathology. Currently, the diagnosis of depression is made based on clinical manifestations, with little objective evidence. Magnetic resonance imaging (MRI) has been used to investigate the pathological changes in brain anato...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12835

    authors: Zhang FF,Peng W,Sweeney JA,Jia ZY,Gong QY

    更新日期:2018-11-01 00:00:00

  • Cannabidiol: a promising drug for neurodegenerative disorders?

    abstract::Neurodegenerative diseases represent, nowadays, one of the main causes of death in the industrialized country. They are characterized by a loss of neurons in particular regions of the nervous system. It is believed that this nerve cell loss underlies the subsequent decline in cognitive and motor function that patients...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2008.00065.x

    authors: Iuvone T,Esposito G,De Filippis D,Scuderi C,Steardo L

    更新日期:2009-01-01 00:00:00

  • Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

    abstract::Appropriate and reliable classification of mental illness is crucial for advancing the field of psychiatry as agreement on diagnosis has broad implications for treatment of mental disorders and research into the etiopathophysiology of mental disorders. Since schizophrenia was first recognized by Kraepelin (as dementia...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00229.x

    authors: Keller WR,Fischer BA,Carpenter WT Jr

    更新日期:2011-04-01 00:00:00

  • The impact of brain-derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy.

    abstract:INTRODUCTION:Medial temporal lobe epilepsy (mTLE) is the most common refractory focal epilepsy in adults. Around 30%-40% of patients have prominent memory impairment and experience significant postoperative memory and language decline after surgical treatment. BDNF Val66Met polymorphism has also been associated with co...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13003

    authors: Sidhu MK,Thompson PJ,Wandschneider B,Foulkes A,de Tisi J,Stretton J,Perona M,Thom M,Bonelli SB,Burdett J,Williams E,Duncan JS,Matarin M

    更新日期:2019-02-01 00:00:00

  • Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.

    abstract:AIM:To compare atomoxetine (ATX) length of therapy (LoT) among adults with ADHD who reached the recommended dose of 80 mg/day (ATX ≥ 80) versus those who did not (ATX < 80) analyzed separately in patients prescribed ATX as monotherapy (mono) and in combination with other ADHD medications (combo). METHODS:This was a re...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12595

    authors: Clemow DB,Nyhuis AW,Robinson RL

    更新日期:2016-12-01 00:00:00

  • Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.

    abstract::Insulin-Like Growth Factor-1 (IGF-1) is neuroprotective and improves long-term function after brain injury. However, its clinical application to neurological disorders is limited by its large molecular size, poor central uptake, and mitogenic potential. Glycine-proline-glutamate (GPE) is naturally cleaved from the IGF...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2009.00128.x

    authors: Guan J

    更新日期:2011-08-01 00:00:00

  • Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain.

    abstract:AIMS:Blood-borne monocytes/macrophages infiltrate the brain in massive numbers after ischemic stroke, but their impact on poststroke brain injury and recovery remains elusive. This study examined the transcriptomic changes in monocytes/macrophages after ischemic stroke and the functional implications of these changes, ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13256

    authors: Zhang W,Zhao J,Wang R,Jiang M,Ye Q,Smith AD,Chen J,Shi Y

    更新日期:2019-12-01 00:00:00

  • Inhibition of transient potential receptor vanilloid type 1 suppresses seizure susceptibility in the genetically epilepsy-prone rat.

    abstract:AIMS:Intracellular calcium plays an important role in neuronal hyperexcitability that leads to seizures. One calcium influx route of interest is the transient receptor potential vanilloid type 1 (TRPV1) channel. Here, we evaluated the effects of capsazepine (CPZ), a potent blocker of TRPV1 channels on acoustically evok...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12770

    authors: Cho SJ,Vaca MA,Miranda CJ,N'Gouemo P

    更新日期:2018-01-01 00:00:00

  • Effect of exosomes from adipose-derived stem cells on the apoptosis of Schwann cells in peripheral nerve injury.

    abstract:AIMS:Recovery after peripheral nerve injury (PNI) is often difficult, and there is no optimal treatment. Schwann cells (SCs) are important for peripheral nerve regeneration, so SC-targeting treatments have gained importance. Adipose-derived stem cells (ADSCs) and their exosomes can promote peripheral nerve repair, but ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13187

    authors: Liu CY,Yin G,Sun YD,Lin YF,Xie Z,English AW,Li QF,Lin HD

    更新日期:2020-02-01 00:00:00

  • EF1A1/HSC70 Cooperatively Suppress Brain Endothelial Cell Apoptosis via Regulating JNK Activity.

    abstract:AIMS:In our previous study, eEF1A1 was identified to be a new target for protecting brain ischemia injury, but the mechanism remains largely unknown. In this study, we screened the downstream cellular protein molecules interacted with eEF1A1 and found mechanism of eEF1A1 in brain ischemia protection. METHODS AND RESUL...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12581

    authors: Liu Y,Jiang S,Yang PY,Zhang YF,Li TJ,Rui YC

    更新日期:2016-10-01 00:00:00

  • Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

    abstract::Central dopaminergic and noradrenergic systems play essential roles in controlling several forebrain functions. Consequently, perturbations of these neurotransmissions may contribute to the pathophysiology of neuropsychiatric disorders. For many years, there was a focus on the serotonin (5-HT) system because of the ef...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00146.x

    authors: El Mansari M,Guiard BP,Chernoloz O,Ghanbari R,Katz N,Blier P

    更新日期:2010-06-01 00:00:00

  • A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

    abstract:AIM:Multiple sclerosis (MS) is a neurological autoimmune disorder characterized by mistaken attacks of inflammatory cells against the central nervous system (CNS), resulting in demyelination and axonal damage. Kv1.3 channel blockers can inhibit T-cell activation and have been designed for MS therapy. However, little is...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12848

    authors: Yuan XL,Zhao YP,Huang J,Liu JC,Mao WQ,Yin J,Peng BW,Liu WH,Han S,He XH

    更新日期:2018-10-01 00:00:00

  • High salt intake and stroke: meta-analysis of the epidemiologic evidence.

    abstract::Research on the potential impact of high salt intake on health has grown rapidly over the last decades. Recent studies have suggested that high salt intake could also be associated with adverse effects on cardiovascular system. The review evaluated the current level of epidemiologic evidence on the association between...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/j.1755-5949.2012.00355.x

    authors: Li XY,Cai XL,Bian PD,Hu LR

    更新日期:2012-08-01 00:00:00

  • Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

    abstract::5-HT(1A) receptors have long been implicated in the pathogenesis and treatment of anxiety and depressive disorders. Recently, several lines of studies have revealed new insights into the therapeutic role of 5-HT(1A) receptors in treating schizophrenia and Parkinson's disease. Specifically, 5-HT(1A) receptors seem to b...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00211.x

    authors: Ohno Y

    更新日期:2011-02-01 00:00:00

  • Endothelial glycocalyx as an important factor in composition of blood-brain barrier.

    abstract::The blood-brain barrier is a dynamic and complex neurovascular unit that protects neurons from somatic circulatory factors as well as regulates the internal environmental stability of the central nervous system. Endothelial glycocalyx is a critical component of an extended neurovascular unit that influences the struct...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13560

    authors: Zhao F,Zhong L,Luo Y

    更新日期:2020-12-30 00:00:00

  • A brain network model for depression: From symptom understanding to disease intervention.

    abstract::Understanding the neural substrates of depression is crucial for diagnosis and treatment. Here, we review recent studies of functional and effective connectivity in depression, in terms of functional integration in the brain. Findings from these studies, including our own, point to the involvement of at least four net...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12998

    authors: Li BJ,Friston K,Mody M,Wang HN,Lu HB,Hu DW

    更新日期:2018-11-01 00:00:00

  • Treatment of status epilepticus with ketamine, are we there yet?

    abstract::Status epilepticus (SE), a neurological emergency both in adults and in children, could lead to brain damage and even death if untreated. Generalized convulsive SE (GCSE) is the most common and severe form, an example of which is that induced by organophosphorus nerve agents. First- and second-line pharmacotherapies a...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12096

    authors: Dorandeu F,Dhote F,Barbier L,Baccus B,Testylier G

    更新日期:2013-06-01 00:00:00

  • Chronic sleep fragmentation shares similar pathogenesis with neurodegenerative diseases: Endosome-autophagosome-lysosome pathway dysfunction and microglia-mediated neuroinflammation.

    abstract:AIMS:Insufficient sleep has been found to result in varying degrees of cognitive impairment and emotional changes. Sleep was reported probably responsible for cleaning metabolic wastes in brain by increasing extracellular bulk flow. Herein, we propose that chronic sleep insufficiency in young adult wild-type mice is al...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13218

    authors: Xie Y,Ba L,Wang M,Deng SY,Chen SM,Huang LF,Zhang M,Wang W,Ding FF

    更新日期:2020-02-01 00:00:00

  • A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.

    abstract::A multisite, double-blind, placebo-controlled trial of bupropion for methamphetamine dependence was reanalyzed using a novel, nonbinary method of evaluating success and failure. The original analysis focused on a group response endpoint (the change in percentage of participants with methamphetamine-free urines each we...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1755-5949.2011.00263.x

    authors: McCann DJ,Li SH

    更新日期:2012-05-01 00:00:00

  • Development and validation of a new score for predicting functional outcome of neurocritically ill patients: The INCNS score.

    abstract:AIMS:To develop and validate a novel score for prediction of 3-month functional outcome in neurocritically ill patients. METHODS:The development of the novel score was based on two widely used scores for general critical illnesses (Acute Physiology and Chronic Health Evaluation II, APACHE II; Simplified Acute Physiolo...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13134

    authors: Gao Q,Yuan F,Yang XA,Zhu JW,Song L,Bi LJ,Jiao ZY,Kang XG,Yang F,Jiang W

    更新日期:2020-01-01 00:00:00

  • Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.

    abstract::Tolerance development after successful long-term treatment of bipolar disorder is under recognized, as are ways to prevent or show its occurrence or reverse it once it has occurred. We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present a...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00215.x

    authors: Post RM,Weiss SR

    更新日期:2011-12-01 00:00:00